Saltar al contenido
Merck

Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation.

American journal of hypertension (2005-06-01)
Riccardo Candido, Michele Carraro, Francesco Fior, Mary L Artero, Cristina Zennaro, Louise M Burrell, Belinda J Davis, Maria Rosa Cattin, Moreno Bardelli, Luigi Faccini, Renzo Carretta, Bruno Fabris
RESUMEN

The aim of the present study was to compare glomerular permeability alterations associated with experimental hypertension models known to have different effects on the circulating renin-angiotensin system (RAS). Five groups, 10 animals each, were studied. One group served as a nonhypertensive control. The other four groups of hypertensive animals were composed of spontaneously hypertensive rats, deoxycorticosterone acetate hypertensive rats, Goldblatt two-kidney, one-clip rats, and a group of Wistar rats infused with angiotensin II (200 ng/kg/min). Tail-cuff sphygmomanometric systolic blood pressure (BP), albumin permeability determined in isolated glomeruli exposed to oncotic gradients (P(alb)), glomerular filtration rate (GFR, iopamidol method), plasma renin activity (PRA), and albuminuria were evaluated. Alterations in P(alb) and albumin excretion rate were more evident in the experimental models with an activation of the RAS despite similar levels of systolic BP and GFR. A positive correlation was found between P(alb) and albuminuria (r = 0.51; P < .001) and between systolic BP and albuminuria (r = 0.37; P < .01). No relation was found between systolic BP and P(alb). The present study indicates that the activation of the RAS plays a significant role in the development of glomerular albumin permeability defects in hypertensive models and may contribute to the mechanisms that lead to target organ damage in hypertension.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Deoxycorticosterone acetate
Deoxycorticosterone acetate, European Pharmacopoeia (EP) Reference Standard